Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer's disease by regulating cilia function

被引:64
|
作者
Hu, Lili [1 ]
Wang, Bingjie [1 ]
Zhang, Yan [1 ]
机构
[1] Peking Univ, PKU IDG McGovern Inst Brain Res, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Room 239, Beijing 100871, Peoples R China
来源
ALZHEIMERS RESEARCH & THERAPY | 2017年 / 9卷
基金
美国国家科学基金会;
关键词
5-HT6; Cilia; Axon; Axon initial segment; Alzheimer's disease; BARDET-BIEDL-SYNDROME; TYPE-3; ADENYLYL-CYCLASE; AXON INITIAL SEGMENT; ASSOCIATION ANALYSIS; POLYMORPHISM C267T; NEURONAL CILIA; RAT-BRAIN; LOCALIZATION; ANTAGONIST; MEMORY;
D O I
10.1186/s13195-017-0304-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Serotonin receptor 5-HT6 is involved in cognition and Alzheimer's disease (AD) development. However, the mechanism of 5-HT6 in AD pathology is not clear. Methods: Since 5-HT6 is almost exclusively expressed in the primary cilia, using immunostaining we examined the number of cilia in the hippocampus of AD animal model APP/PS1 mice. By overexpressing and knocking down 5-HT6 in the primary cultured hippocampal neurons, we investigated the roles of 5-HT6 in alternating ciliary morphology. Furthermore, 5-HT6 antagonist was applied to confirm its roles in cognition using the Morris water maze test, Y maze, and fear conditioning. Results: In the present study, we found that the primary cilia were elongated in the hippocampus of APP/PS1 mice compared with WT mice. 5-HT6 regulated cilia length, influenced cilia and axon initial segment (AIS) morphology, and affected localization of ARL13B and AnkG. We also found that, by changing cilia morphology, the AIS was elongated, branched, and more proximal to the cell body in both WT and APP/PS1 mouse neurons. Alterations of cilia also decreased the axonal length in WT and APP/PS1 neurons. Furthermore, in the water maze test, Y maze, and fear conditioning test, 5-HT6 antagonist SB271046 recovered the cognitive impairment of APP/PS1 mice. Conclusion: We suggest that 5-HT6 plays a critical role in AD development through regulating the morphology and function of neuronal primary cilia, which is possibly related to the AIS and axon alterations in AD development.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function
    Lili Hu
    Bingjie Wang
    Yan Zhang
    Alzheimer's Research & Therapy, 9
  • [2] 5-HT6 receptors and Alzheimer's disease
    Javier Ramirez, Maria
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (02)
  • [3] 5-HT6 receptors: Serotonin Signaling via the Primary Neuronal Cilia
    Neumaier, John F.
    Brodsky, Matthew
    Sullivan, Jane
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 290S - 290S
  • [4] The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease
    Geldenhuys, Werner J.
    Van der Schyf, Cornelis J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (07) : 1073 - 1085
  • [5] Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
    Lalut, Julien
    Karila, Delphine
    Dallemagne, Patrick
    Rochais, Christophe
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (08) : 781 - 795
  • [6] Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease
    Wicke, Karsten
    Haupt, Andreas
    Bespalov, Anton
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (12) : 1515 - 1528
  • [7] Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer's disease
    Kucwaj-Brysz, Katarzyna
    Baltrukevich, Hanna
    Czarnota, Kinga
    Handzlik, Jadwiga
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 49
  • [8] THE 5-HT6 RECEPTOR ANTAGONISM APPROACH IN ALZHEIMER'S DISEASE
    Marazziti, D.
    Rutigliano, G.
    Catena-Dell'Osso, M.
    Baroni, S.
    Dell'Osso, L.
    DRUGS OF THE FUTURE, 2014, 39 (02) : 133 - 140
  • [9] Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease
    de Jong, Inge E. M.
    Mork, Arne
    NEUROPHARMACOLOGY, 2017, 125 : 50 - 63
  • [10] Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status
    Ferrero, Hilda
    Solas, Maite
    Francis, Paul T.
    Ramirez, Maria J.
    CNS DRUGS, 2017, 31 (01) : 19 - 32